NeuBase Therapeutics, Inc. - FORM 10-K/A - EX-31.1 - CERTIFICATION OF CHIEF EXECUTIVE OFFICER - December 7, 2016

Attached files

file filename
EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - NeuBase Therapeutics, Inc.ex23-1.htm
EX-31.2 - CERTIFICATION OF CHIEF FINANCIAL OFFICER - NeuBase Therapeutics, Inc.ex31-2.htm
10-K/A - AMENDMENT TO FORM10-K - NeuBase Therapeutics, Inc.ohrp-10ka_093015.htm

 

Ohr Pharmaceutical, Inc. 10-K/A

 

Exhibit 31.1

 

Certification of Chief Executive Officer
Pursuant to Section 302 of the
Sarbanes-Oxley Act of 2002

I, Jason Slakter, certify that:

 

  1. I have reviewed this report on Form 10-K of Ohr Pharmaceutical, Inc; and

 

  2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.

 

Dated: December 7, 2016

 

/s/ Jason Slakter  
Jason Slakter  
Chief Executive Officer (Principal Executive Officer)  

 

 

 

 

 

NeuBase Therapeutics, Inc. Reports